Allergic rhinitis associated with increased risk of nasopharyngeal cancer
the ONA take:
According to a new study published in the journal Head & Neck, researchers in Taiwan have found that patients with allergic rhinitis may have an increased risk of developing nasopharyngeal carcinoma.
For the study, researchers from the National Defense Medical Center in Taipei, Taiwan, analyzed data from 67,532 patients with allergic rhinitis and 135,054 age- and sex-matched controls from the Taiwan Longitudinal Health Insurance Database.
Results showed that patients with allergic rhinitis had a 2.33-fold increased risk of developing nasopharyngeal carcinoma compared to their matched controls.
In addition, researchers found that patients who had four or more visits to their healthcare provider for allergic rhinitis had a significantly increased risk of developing nasopharyngeal carcinoma.
The authors note that the underlying mechanism for the association is unknown, but hypothesize that a malignant change may occur due to chronic repeated airway stimulation and inflammation, epithelial cell changes, and reduced mucociliary clearance.
The American Cancer Society estimates that there will be approximately 3,200 new cases of nasopharyngeal carcinoma in the United States in 2015. Despite being fairly rare in the United States, nasopharyngeal carcinoma is more more common in certain parts of Asia and North Africa, and among recent Chinese and Hmong immigrants in the United States.
Patients with allergic rhinitis may have an increased risk of developing nasopharyngeal carcinoma.
Sign Up for Free e-newsletters
- Distress, Neuroticism Predict Long-term Emotional Distress After Cancer Diagnosis
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- Patient Satisfaction Ratings Can Be Negatively Impacted by Nurse Staffing Ratio
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- Bacteria in Probiotics Carry Potential Risks for Immunocompromised Patients
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
- Overall Survival Prolonged With HIPEC + Cytoreductive Surgery for Gastric Cancer
- Better Postoperative Outcomes With RAMIE for Esophageal Cancer
- Distinct Patterns of Shiny White Streaks Strong Indicator of Melanoma
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|